Girard Partners’s Regeneron Pharmaceuticals REGN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q2 | $11.4M | Sell |
|
|||||
|
2024
Q1 | $10.5M | Buy |
|
|||||
|
2023
Q4 | $9.52M | Buy |
|
|||||
|
2023
Q3 | $8.71M | Buy |
|
|||||
|
2023
Q2 | $7.51M | Sell |
|
|||||
|
2023
Q1 | $9.34M | Buy |
|
|||||
|
2022
Q4 | $6.16M | Buy |
|
|||||
|
2022
Q3 | $5.64M | Buy |
|
|||||
|
2022
Q2 | $3.64M | Sell |
|
|||||
|
2022
Q1 | $4.53M | Sell |
|
|||||
|
2021
Q4 | $4.22M | Buy |
|
|||||
|
2021
Q3 | $3.87M | Buy |
|
|||||
|
2021
Q2 | $3.54M | Buy |
|
|||||
|
2021
Q1 | $2.71M | Buy |
|
|||||
|
2018
Q4 | – | Sell |
|
|||||
|
2018
Q3 | $27K | Buy |
|
|||||
|
2017
Q4 | – | Sell |
|
|||||
|
2017
Q3 | $209K | Sell |
|
|||||
|
2017
Q2 | $267K | Buy |
|